1.
J Med Chem
; 58(3): 1426-41, 2015 Feb 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25587754
RESUMO
The structure-based design and optimization of a novel series of selective PERK inhibitors are described resulting in the identification of 44 as a potent, highly selective, and orally active tool compound suitable for PERK pathway biology exploration both in vitro and in vivo.